Skip to main content

NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022.

Publication ,  Journal Article
Wood, DE; Kazerooni, EA; Aberle, D; Berman, A; Brown, LM; Eapen, GA; Ettinger, DS; Ferguson, JS; Hou, L; Kadaria, D; Klippenstein, D; Kumar, R ...
Published in: J Natl Compr Canc Netw
July 2022

The NCCN Guidelines for Lung Cancer Screening recommend criteria for selecting individuals for screening and provide recommendations for evaluation and follow-up of lung nodules found during initial and subsequent screening. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Lung Cancer Screening.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

July 2022

Volume

20

Issue

7

Start / End Page

754 / 764

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Mass Screening
  • Lung Neoplasms
  • Humans
  • Early Detection of Cancer
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wood, D. E., Kazerooni, E. A., Aberle, D., Berman, A., Brown, L. M., Eapen, G. A., … Hughes, M. (2022). NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Canc Netw, 20(7), 754–764. https://doi.org/10.6004/jnccn.2022.0036
Wood, Douglas E., Ella A. Kazerooni, Denise Aberle, Abigail Berman, Lisa M. Brown, Georgie A. Eapen, David S. Ettinger, et al. “NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022.J Natl Compr Canc Netw 20, no. 7 (July 2022): 754–64. https://doi.org/10.6004/jnccn.2022.0036.
Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, et al. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Canc Netw. 2022 Jul;20(7):754–64.
Wood, Douglas E., et al. “NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022.J Natl Compr Canc Netw, vol. 20, no. 7, July 2022, pp. 754–64. Pubmed, doi:10.6004/jnccn.2022.0036.
Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, Ettinger DS, Ferguson JS, Hou L, Kadaria D, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Mazzone P, Merritt RE, Midthun DE, Onaitis M, Pipavath S, Pratt C, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Studts JL, Tanoue L, Tong BC, Travis WD, Wei B, Westover K, Yang SC, McCullough B, Hughes M. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Canc Netw. 2022 Jul;20(7):754–764.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

July 2022

Volume

20

Issue

7

Start / End Page

754 / 764

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Mass Screening
  • Lung Neoplasms
  • Humans
  • Early Detection of Cancer
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis